MAPK3 and ovarian carcinoma: For prostate cancer samples, no difference in signal intensity could be detected between both preservation methods, and phospho-Erk-1/2 could not be detected in or could be detected at very low levels in cryopreserved and PFPE ovarian cancer tissues by ELISA or western blot analysis (Figure 3E and F).